IMLFF - InMed Pharmaceuticals reports Q3 results May, 14 2020 07:35 AM InMed Pharmaceuticals Inc. InMed Pharmaceuticals (OTCQX:IMLFF): Q3 GAAP EPS of -C$0.02.Cash, cash equivalents and short-term investments were of C$9.4M.Press ReleaseMore news on: InMed Pharmaceuticals Inc., Earnings news and commentary, Tech stocks news, ,